In the 2011 research, EGCG was proven to become an androgen antagonist; when included to prostate cancer cells, EGCG physically interacted With all the androgen receptor’s ligand-binding area.Reference citations in certain PDQ most cancers facts summaries may incorporate inbound links to exterior websites which are operated by persons or business… Read More